Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR
David Bonsall, William F. Gregory, Camilla L.C. Ip, Sharyne Donfield, James Iles, M. Azim Ansari, Paolo Piazza, Amy Trebes, Anthony Brown, John Frater, Oliver G. Pybus, Phillip Goulder, Paul Klenerman, Rory Bowden, Edward D. Gomperts, Eleanor Barnes, Amit Kapoor, Colin P. Sharp, and Peter Simmonds
Author affiliations: University of Oxford, Oxford, UK (D. Bonsall, C.L.C. Ip, J. Iles, M.A. Ansari, P. Piazza, A. Trebes, A. Brown, J. Frater, O.G. Pybus, P. Goulder, P. Klenerman, R. Bowden, E. Barnes, P. Simmonds); University of Edinburgh Easter Bush, Edinburgh, Scotland, UK (W.F. Gregory, C.P. Sharp); Rho, Inc., Chapel Hill, North Carolina, USA (S. Donfield); The Childrens' Hospital, Los Angeles, California, USA (E.D. Gomperts); The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA (A. Kapoor)
Main Article
Table 2
Detection frequencies of HPgV by sequence library screening and PCR*
Diagnostic method |
Diagnoses and characteristics |
No. tested |
No. (%) HHpgV-1+ |
No. (%) HPgV+ |
Bioinformatics |
|
|
|
|
|
HIV+ |
36 |
0 |
3 (8.3) |
|
HIV+/HCV+/PWID |
30 |
0 |
3 (10.0) |
|
HCV+/PWID
|
120
|
2 (1.7)
|
14 (11.6)
|
PCR |
|
|
|
|
|
Hemophilia† |
195 |
1 (0.5) |
18 (9.2) |
|
Control group‡ |
50 |
0 |
1 (2.0) |
Main Article
Page created: March 15, 2016
Page updated: March 15, 2016
Page reviewed: March 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.